Central 6-hydroxydopamine and renal sodium retention in mineralocorticoid-treated rats

J. L. Hall, T. E. Mecca, R. L. Malvin, R Clinton Webb

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Cerebroventricular administration of 6-hydroxydopamine attenuated the development of deoxycorticosterone hypertension in the rat but did not affect the inital period of renal sodium retention. However, escape from the sodium retention was greater in 6-hydroxydopamine-treated rats. These data support the hypothesis that destruction of central catecholamine-containing neurons influences the renal handling of sodium. The enhanced escape may lead to diminished total body sodium, which attenuates the development of deoxycorticosterone hypertension.

Original languageEnglish (US)
Pages (from-to)1572-1575
Number of pages4
JournalCanadian Journal of Physiology and Pharmacology
Volume64
Issue number12
DOIs
StatePublished - Jan 1 1986
Externally publishedYes

Fingerprint

Mineralocorticoids
Oxidopamine
Sodium
Kidney
Desoxycorticosterone
Hypertension
Catecholamines
Neurons

ASJC Scopus subject areas

  • Physiology
  • Pharmacology
  • Physiology (medical)

Cite this

Central 6-hydroxydopamine and renal sodium retention in mineralocorticoid-treated rats. / Hall, J. L.; Mecca, T. E.; Malvin, R. L.; Webb, R Clinton.

In: Canadian Journal of Physiology and Pharmacology, Vol. 64, No. 12, 01.01.1986, p. 1572-1575.

Research output: Contribution to journalArticle

@article{bb35a65c6e1f4e6aa0f6084c3ef0f1f2,
title = "Central 6-hydroxydopamine and renal sodium retention in mineralocorticoid-treated rats",
abstract = "Cerebroventricular administration of 6-hydroxydopamine attenuated the development of deoxycorticosterone hypertension in the rat but did not affect the inital period of renal sodium retention. However, escape from the sodium retention was greater in 6-hydroxydopamine-treated rats. These data support the hypothesis that destruction of central catecholamine-containing neurons influences the renal handling of sodium. The enhanced escape may lead to diminished total body sodium, which attenuates the development of deoxycorticosterone hypertension.",
author = "Hall, {J. L.} and Mecca, {T. E.} and Malvin, {R. L.} and Webb, {R Clinton}",
year = "1986",
month = "1",
day = "1",
doi = "10.1139/y86-264",
language = "English (US)",
volume = "64",
pages = "1572--1575",
journal = "Canadian Journal of Physiology and Pharmacology",
issn = "0008-4212",
publisher = "National Research Council of Canada",
number = "12",

}

TY - JOUR

T1 - Central 6-hydroxydopamine and renal sodium retention in mineralocorticoid-treated rats

AU - Hall, J. L.

AU - Mecca, T. E.

AU - Malvin, R. L.

AU - Webb, R Clinton

PY - 1986/1/1

Y1 - 1986/1/1

N2 - Cerebroventricular administration of 6-hydroxydopamine attenuated the development of deoxycorticosterone hypertension in the rat but did not affect the inital period of renal sodium retention. However, escape from the sodium retention was greater in 6-hydroxydopamine-treated rats. These data support the hypothesis that destruction of central catecholamine-containing neurons influences the renal handling of sodium. The enhanced escape may lead to diminished total body sodium, which attenuates the development of deoxycorticosterone hypertension.

AB - Cerebroventricular administration of 6-hydroxydopamine attenuated the development of deoxycorticosterone hypertension in the rat but did not affect the inital period of renal sodium retention. However, escape from the sodium retention was greater in 6-hydroxydopamine-treated rats. These data support the hypothesis that destruction of central catecholamine-containing neurons influences the renal handling of sodium. The enhanced escape may lead to diminished total body sodium, which attenuates the development of deoxycorticosterone hypertension.

UR - http://www.scopus.com/inward/record.url?scp=0022881575&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022881575&partnerID=8YFLogxK

U2 - 10.1139/y86-264

DO - 10.1139/y86-264

M3 - Article

VL - 64

SP - 1572

EP - 1575

JO - Canadian Journal of Physiology and Pharmacology

JF - Canadian Journal of Physiology and Pharmacology

SN - 0008-4212

IS - 12

ER -